An underground market for unapproved slimming medications is propelled by social media fitness personalities and vendors on messaging platforms, according to new investigations.
Experimental Drug Gaining Popularity Online
Retatrutide, which is still in research studies, is being promoted by online personalities for its supposed weight-reducing effects. Viewers are encouraged to contact these accounts directly for source information, while also obtaining discount codes.
Thriving Trade on Messaging Platforms
Separately, a robust market exists on messaging services, where communities with thousands of members share “before and after” photos, injection guides and claims of next-day UK delivery. Sellers market the drug there before directing customers to WhatsApp for purchases.
Understanding Retatrutide
Retatrutide is an investigational injectable developed by American pharmaceutical company Eli Lilly. The treatment targets three gut hormones – GLP-1, GIP and pancreatic hormone. Preliminary studies indicate it could assist patients lose up to a quarter of their body weight. Referred to as the “triple G”, the drug is being promoted digitally as the successor to Ozempic.
Healthcare Experts Voice Worries
However, physicians and chemists have warned that the distribution of what remains an unlicensed medication in the UK is a cause for concern and could result in users administering products of unknown origin.
Some professionals stated the demand for retatrutide could be connected to the increasing price of approved weight loss products such as Mounjaro.
Legal Position and Implementation
Marketing retatrutide on social media or Telegram is illegal in the UK, as it is an unapproved drug that cannot be marketed or supplied for personal consumption under the Human Medicines Regulations 2012.
Some influencers try to sidestep the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled substance, but promotion and supply can still violate medicines, marketing, and consumer laws, risking fines, prosecution or imprisonment.
Platform Response and Material Elimination
According to the social media company, the platform has removed problematic content and prohibited related keywords and search suggestions. The company stated it was committed to maintaining the platform secure and investing in strengthening compliance measures.
Online Trading Operations
Investigations also discovered groups with up to 9,000 participants marketing retatrutide using the platform's integrated discovery tool, which functions like a public directory. Entering “retatrutide” instantly displays channels with numerous of users, populated with photos of weight loss, glowing reviews and step-by-step instructions for preparing or administering at home.
After minutes of entering one group, a seller shared contact information, where most transactions take place. The vendor sent an guidebook and promised shipping within 48 hours. When questioned whether the substance was authentic, one vendor said: “You can’t be sure.” Another provided a image of a alleged testing documentation. None inquired about body mass, medical conditions or past usage.
Item Details and Costs
Within these groups, posts show dark colored packages with Royal Mail stickers, claiming to contain new batches. One communication stated: “It took eight of us to load them this morning.”
Buyers can choose between dry substance containers, mixed at home with purified liquid, or pre-filled pens usually sold at 160 pounds for 20mg. When asked how long a injector should last, sellers give contradictory answers varying between a few weeks to “depends on your body”.
Service Moderation and Safety Actions
A representative for the messaging service stated it actively moderated dangerous content on its platform including material that promoted the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.
Medical Professional Cautions
“Individuals are injecting substances they cannot confirm. Although the science behind retatrutide is valid, these online products may not contain what they advertise,” stated Jason Murphy, the head of pharmaceutical services at Chemist4U.
Dr Crystal Wyllie of Asda Online Doctor linked the increase in demand to current price rises for approved slimming drugs such as Mounjaro. “With costs rising, patients are using online platforms. But counterfeit injections are extremely risky. You cannot know what’s contained or whether the environment they were produced in was sterile,” she explained.
Her staff has already encountered patients harmed by personal administration from unverified sources. “We understand the frustration, but buying from Telegram or communication platforms is gambling with your health,” stated Wyllie. “These substances could be contaminated or improperly measured.”
Producer Position
A representative from the pharmaceutical company stated the substance was in third stage clinical trials and had not been evaluated or approved by any regulatory agency anywhere in the world. “Therefore at this point no one can sell [it] for human use,” they explained, noting that any product “falsely representing itself as a company experimental product not yet approved … may expose users to possibly significant health risks”.
